Edetic Acid

Edetic Acid

SCHEMBL144663

O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Cu+2].[Cu+2]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
ALOX15 P16050 2/20 0.68
MAPT P10636 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
TDP1 Q9NUW8 2/20 0.50
EYA2 O00167 1/20 0.50
APP P05067 1/20 0.50
ACE P12821 1/20 0.50
BLM P54132 2/20 0.48
PMP22 Q01453 2/20 0.48
LMNA P02545 1/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
TSHR P16473 1/20 0.48
DRD1 P21728 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
CYP2C19 P33261 1/20 0.48
ADRA1A P35348 1/20 0.48
DRD3 P35462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL18983963 1.00 KDM4E (0.68) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL8933697 0.97 KDM4E (0.65) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL22654038 0.97 KDM4E (0.65) KDM4EALOX15MAPTSMN1; SMN2TDP1
Pentetic Acid SCHEMBL2274186 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL413600 0.97 KDM4E (0.65) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL243998 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL9131150 0.97 KDM4E (0.71) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL9540648 0.94 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL28905272 0.94 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL333822 0.94 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010609-A Crop full-effect biological stimulation hormone based on mineral-enzyme composite technology and preparation method thereof 新疆盐碱科学技术院有限公司 2026-05-12 CN claimed
EP-4717090-A2 PHOSPHORUS ACID AND ALKYLAMINE OR ALKANOLAMINE STABILIZED COPPER COMPOUND CONTAINING COMPOSITIONS FOR CONTROLLING A PLANT DISEASE CAUSED BY A PHYTOPATHOGENIC ORGANISM Nutriag Ltd. (CA) 2026-04-01 EP claimed
US-12557816-B2 Compositions for controlling a plant disease NUTRIAG LTD. (CA) 2026-02-24 US claimed
EP-4626738-A1 PYROTECHNIC SWITCH FOR AN ELECTRIC VEHICLE Ticona LLC (US) 2025-10-08 EP claimed
WO-2025123106-A1 METHOD FOR PRODUCING A POULTRY LITTER-BASED FERTILIZER, POULTRY LITTER-BASED FERTILIZER AND USE OF THE FERTILIZER INTERNATIONAL FERTILIZER DEVELOPMENT CENTER (US) 2025-06-19 WO claimed
CN-119822888-A Solid water-soluble fertilizer and preparation method thereof 内蒙古大地云天化工有限公司 2025-04-15 CN claimed
CN-119797982-A Special foliar fertilizer for liquid wheat and application method thereof 山东康德源农业科技有限公司 2025-04-11 CN claimed
CN-116036182-B Solution for preventing and treating cow hoof diseases and preparation method thereof 瑞普(天津)生物药业有限公司 2025-03-07 CN claimed
CN-119552500-A Process for the preparation of polyamide materials with improved long-term use L.布吕格曼两合公司 2025-03-04 CN claimed
CN-119330755-A Liquid fertilizer based on meat and bone powder and application thereof 广东省农业科学院蚕业与农产品加工研究所 2025-01-21 CN claimed
EP-0920327-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS Southern Illinois University (US) 1999-06-09 EP claimed
US-5863603-A Liquid vapor deposition or etching method MICRON TECHNOLOGY, INC. (US) 1999-01-26 US claimed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 WO claimed
US-5454850-A Plant nutrients; source of calcium, phosphorus and other minerals OMS INVESTMENTS, INC. (US) 1995-10-03 US claimed
US-5328616-A Chelation of formates; pollution control MONSANTO COMPANY (US) 1994-07-12 US claimed
WO-1994012439-A1 METHODS AND APPARATUS FOR TREATING ELECTROLESS PLATING BATHS MONSANTO COMPANY (US) 1994-06-09 WO claimed
US-5318908-A Adding a water soluble copper compound and agitating by stirring blades NITTO KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-06-07 US claimed
US-5286272-A FREE-FLOWING OMS INVESTMENTS, INC. 1994-02-15 US claimed
US-4959216-A Contraceptive methods and delivery systems thereof UNIVERSITY OF QUEENSLAND (AU) 1990-09-25 US claimed
US-4597806-A PRECIPITATING NICKEL WITH DIMETHYLGLYOXIME;ADDING SOLUBLE COPPER C PARKER CHEMICAL COMPANY (US) 1986-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12557816-B2 Compositions for controlling a plant disease PHOSPHO1, AOC2, AOC1 KDM4E 3437/4885ALOX15 811/4885MAPT 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.